ArticlemAbs2016

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.

Con Panousis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.